Table 2. Samples collected and similarity analysis summary for each participant.
| Participant | Chronic/acute | Pre-ART | ATI | Cell subsets | LPMCs | CD4 DNA||ATI | CD4 RNA||ATI | Cell subsets||ATI | LPMC||ATI |
|---|---|---|---|---|---|---|---|---|---|
| Pan01 | C | Y | Y | Y | Y | Y | Y | N | N |
| Pan02 | C | Y | Y | Y | N | Y | Y | Y | — |
| Pan04 | A | Y | Y | Y | N | Y* | N | Y* | — |
| Pan05 | A | N | N | N | Y | — | — | — | — |
| Pan06 | C | Y | N | N | N | — | — | — | — |
| Pan07 | C | Y | N | N | Y | — | — | — | — |
| Pan08 | C | N | Y | Y | N | N | N | N | — |
| Pan09 | C | N | Y | Y | Y | Y | N | N | Y |
| Pan10 | C | Y | Y | Y | Y | Y | N | N | N |
| Pan12 | C | Y | Y | Y | N | Y | N | Y | — |
| Pan14 | A | Y | N | N | Y | — | — | — | — |
| Pan15 | C | Y | N | N | Y | — | — | — | — |
| Pan17 | C | N | Y | Y | Y | Y | N | N | Y |
| Pan18 | C | Y | Y | N | Y | Y | Y | — | Y |
| Pan19 | C | N | N | N | N | — | — | — | — |
| 12/15 | 10 | 9 | 8 | 9 | 8/9 | 3/9 | 3/8 | 3/5 |
A, acute; ART, antiretroviral therapy; ATI, analytical treatment interruption; C, chronic; CD4, CD4+ T cell; LPMC, lamina propria mononuclear cell; N, no, Y, yes.
—, sample not available. *Acutely treated participant with average pairwise distance less than 0.005.